Yasumitsu Tomishima

469 total citations
12 papers, 395 citations indexed

About

Yasumitsu Tomishima is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Yasumitsu Tomishima has authored 12 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 4 papers in Pharmacology. Recurrent topics in Yasumitsu Tomishima's work include Cannabis and Cannabinoid Research (4 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Forensic Toxicology and Drug Analysis (3 papers). Yasumitsu Tomishima is often cited by papers focused on Cannabis and Cannabinoid Research (4 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Forensic Toxicology and Drug Analysis (3 papers). Yasumitsu Tomishima collaborates with scholars based in Japan. Yasumitsu Tomishima's co-authors include Takayuki Seki, Noriyuki Miyata, S. Kametani, Masakazu Sato, Kazuya Kameo, Mariko Sato‐Watanabe, Tomokazu Ueki, Yoshiko Yasuda, Kazuo Taniguchi and Mariko Doi and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, British Journal of Pharmacology and Tetrahedron Letters.

In The Last Decade

Yasumitsu Tomishima

12 papers receiving 381 citations

Peers

Countries citing papers authored by Yasumitsu Tomishima

Since Specialization

Citations

This map shows the geographic impact of Yasumitsu Tomishima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasumitsu Tomishima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasumitsu Tomishima more than expected).

Fields of papers citing papers by Yasumitsu Tomishima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasumitsu Tomishima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasumitsu Tomishima. The network helps show where Yasumitsu Tomishima may publish in the future.

Co-authorship network of co-authors of Yasumitsu Tomishima

This figure shows the co-authorship network connecting the top 25 collaborators of Yasumitsu Tomishima. A scholar is included among the top collaborators of Yasumitsu Tomishima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasumitsu Tomishima. Yasumitsu Tomishima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	A Novel Potent and Selective Histamine H3 Receptor Antagonist Enerisant: In Vitro Profiles, In Vivo Receptor Occupancy, and Wake-Promoting and Procognitive Effects in Rodents 2020 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), (unknown), (unknown), Toshiharu Shimazaki, (unknown), Hirohiko Hikichi, Jun-ichi Karasawa, Yasumitsu Tomishima, (unknown), (unknown), (unknown), Toshio Nakamura, Shigeyuki Chaki	12
2	Antipsychotic profiles of TASP0443294, a novel and orally active positive allosteric modulator of metabotropic glutamate 2 receptor 2015 ·Journal of Pharmacological Sciences ·Hirohiko Hikichi, (unknown), (unknown), Yasumitsu Tomishima, (unknown), Izumi Iida, (unknown), (unknown), Akito Yasuhara, Jun-ichi Karasawa, Shigeyuki Chaki	22
3	Neurophysiologic and Antipsychotic Profiles of TASP0433864, a Novel Positive Allosteric Modulator of Metabotropic Glutamate 2 Receptor 2014 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), (unknown), Hirohiko Hikichi, Yasumitsu Tomishima, (unknown), (unknown), Izumi Iida, Akito Yasuhara, Jun-ichi Karasawa, Shigeyuki Chaki	24
4	ChemInform Abstract: N‐Alkylidenearylcarboxamides as New Potent and Selective CB₂ Cannabinoid Receptor Agonists with Good Oral Bioavailability. 2008 ·ChemInform ·Hiroshi Ohta, (unknown), (unknown), (unknown), Izumi Iida, Yasumitsu Tomishima, Yoshihisa Toda, Shuji Saito	2
5	Sulfonamide derivatives as new potent and selective CB2 cannabinoid receptor agonists 2007 ·Bioorganic & Medicinal Chemistry Letters ·Hiroshi Ohta, (unknown), (unknown), (unknown), Yasumitsu Tomishima, Yoshihisa Toda, Shuji Saito	18
6	N-Alkylidenearylcarboxamides as new potent and selective CB2 cannabinoid receptor agonists with good oral bioavailability 2007 ·Bioorganic & Medicinal Chemistry Letters ·Hiroshi Ohta, (unknown), (unknown), (unknown), Izumi Iida, Yasumitsu Tomishima, Yoshihisa Toda, Shuji Saito	33
7	Imine derivatives as new potent and selective CB2 cannabinoid receptor agonists with an analgesic action 2007 ·Bioorganic & Medicinal Chemistry ·Hiroshi Ohta, (unknown), (unknown), (unknown), Izumi Iida, Tomomi Yamaguchi, Yasumitsu Tomishima, Nobuko Futaki, Yoshihisa Toda, Shuji Saito	36
8	Design and synthesis of 1-(4-benzoylphenyl)imidazole derivatives as new potent 20-HETE synthase inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·Toshio Nakamura, Takaaki Ishii, Noriyuki Miyata, Kazuo Taniguchi, Yasumitsu Tomishima, Tomokazu Ueki, Masakazu Sato	4
9	Sphingomyelin analogues as inhibitors of sphingomyelinase 2003 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Kenichi Goda, (unknown), Kyoko Yamamoto, Taizo Suzuki, Yasumitsu Tomishima, (unknown), Koshi Arai, Kenzo Takahashi, Takeo Kobori	25
10	Biological evaluation of sphingomyelin analogues as inhibitors of sphingomyelinase 2003 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Kenichi Goda, (unknown), (unknown), Kyoko Yamamoto, Taizo Suzuki, Yasumitsu Tomishima, (unknown), Koshi Arai, Kenzo Takahashi, Takeo Kobori	21
11	Xantholipin, a novel inhibitor of HSP47 gene expression produced by Streptomyces sp. 2003 ·Tetrahedron Letters ·(unknown), Yiwen Chu, (unknown), (unknown), Haruaki Yamamoto, (unknown), Yasumitsu Tomishima, Saeko Uchida, (unknown), (unknown), Takayuki Seki, Koji Yamamoto, Shigeru Murakami, Akira Kawashima	31
12	HET0016, a potent and selective inhibitor of 20‐HETE synthesizing enzyme 2001 ·British Journal of Pharmacology ·Noriyuki Miyata, Kazuo Taniguchi, Takayuki Seki, (unknown), Mariko Sato‐Watanabe, Yoshiko Yasuda, Mariko Doi, S. Kametani, Yasumitsu Tomishima, Tomokazu Ueki, Masakazu Sato, Kazuya Kameo	167

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact